A weak spot in DNA is present in 95% of IBD cases, allowing immune cells to drive excessive inflammation. Existing drugs show promise in reversing disease in lab, moving towards human trials.
Macrophages release cytokines causing massive inflammation in the intestines. Genetic study reveals a DNA section that regulates this process, offering potential for IBD treatment.
[
add
]
[
|
|
...
]